Table.
The Microbiome and Weight
| Source | Study Subjects | Comparison | No. of Subjects | Method | Taxonomic Findings | Functional Findings |
|---|---|---|---|---|---|---|
| Studies in Obesity and Medical Weight Loss | ||||||
| Armougam et al,11 2009 | Humans | Anorexic, healthy, and obese | 49 | 16S qPCR | Phylum Firmicutes overall had no changes between groups; Lactobacillus species (phylum Firmicutes) increased in the obese group; phylum Bacteroidetes decreased in obese group | NA |
| Arumugam et al,8 2011 | Humans | No specific comparison; BMI in only 6 classified as obese | 37 | Metagenomics | Phyla not related to BMI | F-type ATPase levels increased with increasing BMI |
| Balamurugan et al,12 2010 | Adolescent humans | Obese vs nonobese | 28 | 16S qPCR | Bacteroides, Prevotella, and Porphyromonas species (phyla Bacteroidetes), Bifidobacterium species (phylum Actinobacteria), and Eubacterium rectale (phylum Firmicutes) all unchanged; Faecalibacterium prausnitzii (phylum Firmicutes) increased in obesity | NA |
| Duncan et al,13 2008 | Humans | Obese, nonobese, and obese using a weight-loss diet | 47 | FISH | Decreased phylum Firmicutes in obese subjects with weight-loss diet; no changes in phylum Bacteroidetes between nonobese and obese or in obese after weight loss | NA |
| Ley et al,14 2005 | Mice | Ob/ob vs lean with a normal diet | 19 | 16S Sequencing | Firmicutes to Bacteroidetes ratio increased in obesity | NA |
| Ley et al,10 2006 | Obese humans | Before and after weight-loss diet (restricted fat or carbohydrate intake) | 12 | 16S Sequencing | Firmicutes to Bacteroidetes ratio increased in baseline obesity and decreased with weight-loss diet; increases in phylum Bacteroidetes correlated with weight lost | NA |
| Nadal et al,15 2009 | Obese adolescent humans | Before and after 10-wk calorie-restricted diet | 39 | FISH | Low-weight-loss group showed no significant differences; high-weight-loss group showed significant decreases in Clostridium (phylum Firmicutes) and increases in Bacteroides and Prevotella species (phylum Bacteroidetes) | Trend toward reduction in fecal energy content in high-weight-loss group |
| Santacruz et al,16 2009 | Obese adolescent humans | Before and after diet and exercise for 10 wk | 36 | 16S qPCR | Firmicutes to Bacteroidetes ratio decreased after weight loss and increased at baseline in group with less weight loss | NA |
| Schwiertz et al,17 2010 | Humans | Stratified by BMI (cutoffs 25 and 30) | 98 | 16S qPCR | Firmicutes to Bacteroidetes ratio decreased in obesity; Methanobrevibacter species decreased in obesity | SCFA stool content increased in obesity |
| Turnbaugh et al,18 2006 | Same animals as Ley et al14 (PNAS) | Ob/ob vs lean with a normal diet | 19 | Metagenomics | Same findings as Ley et al14 | Phylum Bacteroidetes associated with carbohydrate metabolism genes and increased SCFA stool content in obesity |
| Turnbaugh et al,20 2009 | Human twins | Stratified by BMI (cutoffs 25 and 30) | 154 | 16S 454 Pyrosequencing and metagenomics | Decreased phylum Bacteroidetes and increased phylum Actinobacteria in obese | Phylum Bacteroidetes associated with carbohydrate metabolism genes and greater diversity than Firmicutes-based genomes |
| Zhang et al,19 2010 | Mice | Wild type vs Apoa-I negative; high-fat vs normal diet | 20 | 16S Pyrosequencing and DGGE | No phyla-order differences observed; diet caused more difference than genotype; Erysipelotrichaceae (phylum Firmicutes) decreased with obesity | NA |
| Studies After RYGB | ||||||
| Furet et al,23 2010 | Humans | Lean controls; obese at baseline and 3 and 6 mo after RYGB | 43 | 16S qPCR | Decreased Bacteroides and Prevotella species in obesity (phylum Bacteroidetes), increasing after RYGB; increased Lactobacillus, Leuconostoc, and Pediococcus species (phylum Firmicutes) and Bifidobacterium (phylum Actinobacteria) in obesity, decreasing after RYGB | Decreased BMI and levels of leptin and inflammatory markers (eg, CRP, IL-6) after RYGB |
| Li et al,25 2011 | Rats | Sham surgery vs RYGB; preoperative vs 2, 4, 6, and 8 wk after RYGB | 12 | 16S Pyrosequencing | Bacteroides species not measured; Lachnospiraceae and Ruminococcaceae (phylum Firmicutes) both decreased after RYGB | Increased fecal amines and cytotoxicity after RYGB |
| Li et al,24 2011 | Rats | Sham surgery vs RYGB; preoperative vs 2, 4, 6, and 8 wk after RYGB | 30 | 16S Pyrosequencing | 52-Fold increase in phylum Proteobacteria after RYGB; decrease in total phyla Firmicutes (4.5-fold) and Bacteroidetes (2-fold), and thus decreased Firmicutes to Bacteroidetes ratio after RYGB | Increased carbohydrate fermentation and protein putrefaction with concomitant rise in gut amines after RYGB |
| Woodard et al,21 2009 | Humans after RYGB | RCT; probiotics (lactobacillus) vs placebo | 44 | Hydrogen breath test | Patients given lactobacillus probiotics (phylum Firmicutes) had increased weight loss compared to those receiving no supplements | Patients given lactobacillus probiotics after RYGB had higher serum levels of vitamin B12 and less bacterial overgrowth via hydrogen breath test |
| Zhang et al,22 2009 | Humans | Control vs obese vs after RYGB (8–15 mo); separate subjects constitute each group | 9 | 16S Pyrosequencing | Prevotellaceae (phylum Bacteroidetes), Coriobacteriaceae (phylum Actinobacteria), Erysipelotrichaceae (phylum Firmicutes), and Alcaligenaceae (phylum Proteobacteria) increased in obese compared with controls Enterobacteriaceae (phylum Proteobacteria) and Fusobacteriaceae (phylum Fusobacteria) markedly increased in the RYGB group; Clostridiales (phylum Firmicutes) decreased in obese and RYGB compared with controls | NA |
Abbreviations: Apoa-I, apolipoprotein A-I; ATPase, adenosine triphosphatase; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CRP, C-reactive protein; DGGE, denaturing gradient gel electrophoresis; FISH, fluorescent in situ hybridization; IL-6, interleukin 6; NA, not available; ob/ob, obese phenotype leptin knockout mice; PNAS, prudent no added salt (diet); qPCR, quantitative polymerase chain reaction; RCT, randomized controlled trial; RYGB, Roux-en-Y gastric bypass; SCFA, short-chain fatty acids.